Mixed Dementias: Clinical Trials

2 trials for Mixed Dementias, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated, 1 unknown. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Terminated 1, Unknown 1
Phase 31Unknown 1

Follow Mixed Dementias: new trials by email Literature Review of Mixed Dementias trials Research Report on Mixed Dementias

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cannabidiol's Role in Dementia Management
Cannabidiol Oil - Dementia, Vascular, Dementia, Mixed
Phase 2 / Phase 3UnknownHospital Pengajar Universiti Putra Malaysia4862024-09-012024-07-23
A Study of the Effects of CY6463 in Participants With Alzheimer's Disease With Vascular Pathology
CY6463, Placebo - Alzheimer's Disease With Vascular Pathology
Phase 2TerminatedTisento Therapeutics122021-11-022024-10-30

Narrower conditions

Dementia, Vascular (2)  ·  Alzheimer Disease (1)

Broader conditions

Arterial Occlusive Diseases (2)  ·  Arteriosclerosis (2)  ·  Brain Diseases (2)  ·  Cardiovascular Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Cerebrovascular Disorders (2)  ·  Dementia (2)  ·  Intracranial Arterial Diseases (2)  ·  Intracranial Arteriosclerosis (2)  ·  Leukoencephalopathies (2)  ·  Mental Disorders (2)  ·  Nervous System Diseases (2)  ·  Neurocognitive Disorders (2)  ·  Vascular Diseases (2)  ·  Neurodegenerative Diseases (1)

Interventions

Cannabidiol (1)

Sponsors

Hospital Pengajar Universiti Putra Malaysia (1)  ·  Tisento Therapeutics (1)

Countries

Malaysia (1)  ·  United States (1)